(Total Views: 538)
Posted On: 06/09/2020 10:45:47 AM
Post# of 121

$ONCS News Article - OncoSec Expands KEYNOTE-890 Trial into First-Line Metastatic Triple Negative Breast Cancer (mTNBC) with TAVO(TM) and KEYTRUDA Plus Chemotherapy https://marketwirenews.com/news-releases/onco...47739.html


My Twitter: WhyteStocks